Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded &ggr;&dgr; T Cells: A Phase I Clinical Study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of immunotherapy

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/CJI.0b013e318207ecfbPMID 21304399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells.

  2010cited by this paper
• Impact of culture medium on the expansion of T cells for immunotherapy.

  2009cited by this paper
• Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients

  2008cited by this paper
• Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

  2008cited by this paper
• Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.

  2008cited by this paper
• A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers

  2008cited by this paper
• Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

  2008cited by this paper
• Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.

  2008cited by this paper
• Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study

  2007cited by this paper
• Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

  2007cited by this paper
• Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.

  2007cited by this paper
• Efficient priming and expansion of antigen‐specific CD8+ T cells by a novel cell‐based artificial APC

  2006cited by this paper
• Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors.

  2006cited by this paper
• Human Vγ9Vδ2 T cells : promising new leads for immunotherapy of infections and tumors

  2006cited by this paper
• Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vγ9Vδ2 naive, memory and effector T cell subsets

  2005cited by this paper
• Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets.

  2005cited by this paper
• γδ T Cell Homeostasis Is Controlled by IL-7 and IL-15 Together with Subset-Specific Factors1

  2005cited by this paper
• Long‐term follow‐up of patients with unresectable locally advanced non‐small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)

  2003cited by this paper
• Gammadelta T cells for immune therapy of patients with lymphoid malignancies.

  2003cited by this paper
• Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells

  2003cited by this paper
• Gammadelta T cells: functional plasticity and heterogeneity.

  2002cited by this paper
• Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

  2002cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• γδ T cells: functional plasticity and heterogeneity

  2002cited by this paper
• [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

  2000cited by this paper
• Gamma/delta T-cell stimulation by pamidronate.

  1999cited by this paper
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.

  1995cited by this paper
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

  1995cited by this paper
• A new microcellular cytotoxicity test based on calcein AM release.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Subpopulations of human peripheral T gamma delta lymphocytes.

  1989cited by this paper
• Subpopulations of human peripheral blood lymphocytes.

  1977cited by this paper

• Aiming Allogeneic γδ T Cells with Tumor-Specific Antibodies via Bioorthogonal Chemistry for Enhanced Solid Tumor Immunotherapy

  2026cites this paper
• Integrating of Radiomics and Single-cell Transcriptomics Uncovers the Crucial Role of γδ T Cells in Lung Adenocarcinoma

  2025cites this paper
• Human γδ T cells in the tumor microenvironment: Key insights for advancing cancer immunotherapy

  2025cites this paper
• Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition

  2025cites this paper
• Gamma delta T cells and their immunotherapeutic potential in cancer

  2025cites this paper
• γδ T Cells: Game Changers in Immune Cell Therapy for Cancer

  2025cites this paper
• Towards the development of next-generation lung cancer immunotherapy

  2025cites this paper
• Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition

  2024cites this paper
• STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of Vδ2+ T cells in acute myeloid leukemia.

  2024cites this paper
• Potential of gamma/delta T cells for solid tumor immunotherapy

  2024cites this paper
• From immunomodulation to therapeutic prospects: Unveiling the biology of butyrophilins in cancer

  2024cites this paper
• Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer

  2024cites this paper
• Effective γδ T‐cell clinical therapies: current limitations and future perspectives for cancer immunotherapy

  2024cites this paper
• T lymphocyte cell: A pivotal player in lung cancer

  2023cites this paper
• Biological characteristics of γδT cells and application in tumor immunotherapy

  2023cites this paper
• Modulation of lytic molecules restrain serial killing in γδ T lymphocytes

  2023cites this paper
• Local γδ T cells: translating promise to practice in cancer immunotherapy

  2023cites this paper
• A close look at current γδ T-cell immunotherapy

  2023cites this paper
• Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques

  2023cites this paper
• NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy

  2023cites this paper
• Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy

  2023cites this paper
• γδ T cells: a sparkling star for clinical immunotherapy

  2022cites this paper
• Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer

  2022cites this paper
• The way of interaction between Vγ9Vδ2 T cells and tumor cells.

  2022cites this paper
• Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches

  2022cites this paper
• γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial Tumors.

  2022cites this paper
• Reviving human γδT cells from apoptosis induced by IL‐12/18 via p‐JNK inhibition

  2022cites this paper
• Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy

  2022cites this paper
• CD137 Costimulation Enhances the Antitumor Activity of Vγ9Vδ2-T Cells in IL-10-Mediated Immunosuppressive Tumor Microenvironment

  2022cites this paper
• Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future

  2022cites this paper
• Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy

  2022cites this paper
• Controversial role of γδ T cells in pancreatic cancer.

  2022cites this paper
• Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis

  2022cites this paper
• Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid

  2022cites this paper
• Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma

  2022cites this paper
• γδT cells: alternative treasure in antitumor immunity

  2022cites this paper
• Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells

  2021cites this paper
• Anti-inflammatory chemoprevention attenuates the phenotype in a mouse model of esophageal adenocarcinoma.

  2021cites this paper
• Adoptive γδT-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancer.

  2021cites this paper
• Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application

  2021cites this paper
• The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting

  2021cites this paper
• Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation.

  2021cites this paper
• The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

  2021cites this paper
• Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells.

  2021cites this paper
• Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy

  2021cites this paper
• Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery

  2021cites this paper
• Targeting butyrophilins for cancer immunotherapy.

  2021cites this paper
• Combinational therapeutics to combat cancer

  2021cites this paper
• Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

  2020cites this paper
• γδ T Cells: The Ideal Tool for Cancer Immunotherapy

  2020cites this paper
• The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy

  2020cites this paper
• Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

  2020cites this paper
• Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?

  2020cites this paper
• Immune cell engineering: opportunities in lung cancer therapeutics

  2020cites this paper
• Suppressive activity of Vδ2+ γδ T cells on αβ T cells is licensed by TCR signaling and correlates with signal strength

  2020cites this paper
• In the Absence of a TCR Signal IL-2/IL-12/18-Stimulated γδ T Cells Demonstrate Potent Anti-Tumoral Function Through Direct Killing and Senescence Induction in Cancer Cells

  2020cites this paper
• Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy

  2020cites this paper
• Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications

  2020cites this paper
• Bi-speci c Antibody Y111, Targeting PD-L1 and CD3 Considerably Enhances the Therapeutic E cacy of Adoptive Transferred Vγ2Vδ2 T Cells

  2020cites this paper
• Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy

  2020cites this paper
• γδ T Cells as Immuno-Oncology Treatments in the Era of Precision Medicine

  2020cites this paper
• Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study

  2020cites this paper
• Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy

  2020cites this paper
• Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study

  2020cites this paper
• Cancer Immunotherapy Confers a Global Benefit

  2020cites this paper
• Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

  2020cites this paper
• Gut γδ T cells as guardians, disruptors, and instigators of cancer

  2020cites this paper
• Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells

  2019cites this paper
• Increase of Tumor Infiltrating &ggr;&dgr; T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppressor, 4-Methylumbelliferone

  2019cites this paper
• Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

  2019cites this paper
• Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.

  2019cites this paper
• PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer

  2019cites this paper
• Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells

  2019cites this paper
• The emerging role of γδ T cells in cancer immunotherapy

  2019cites this paper
• Nutrition, Immunity, and Cancer

  2019cites this paper
• Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

  2019cites this paper
• Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors

  2019cites this paper
• Challenges in assessing solid tumor responses to immunotherapy

  2019cites this paper
• Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer

  2019cites this paper
• Adoptive Immunotherapy and Cellular Therapy

  2019cites this paper
• Title Anti-Tumor Activity and Immunotherapeutic Potential of aBisphosphonate Prodrug

  2018cites this paper
• Expansion of human cd T cells for adoptive immunotherapy using a bisphosphonate prodrug

  2018cites this paper
• Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity

  2018cites this paper
• Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression

  2018cites this paper
• Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib.

  2018cites this paper
• Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

  2018cites this paper
• Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.

  2018cites this paper
• Gamma-delta (γδ) T cells: friend or foe in cancer development?

  2018cites this paper
• Unconventional T Cell Targets for Cancer Immunotherapy.

  2018cites this paper
• Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer

  2018cites this paper
• Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias

  2018cites this paper
• Nano‐technology based carriers for nitrogen‐containing bisphosphonates delivery as sensitisers of &ggr;&dgr; T cells for anticancer immunotherapy

  2017cites this paper
• Tuning cancer fate: the unremitting role of host immunity

  2017cites this paper
• Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model.

  2017cites this paper
• The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.

  2017cites this paper
• γδ T cell-based cancer immunotherapy.

  2017cites this paper
• Zoledronic acid sensitizes rhabdomyosarcoma cells to cytolysis mediated by human γδ T cells.

  2017cites this paper
• Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells

  2017cites this paper
• Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer.

  2017cites this paper
• Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity

  2017cites this paper